These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 28641633)
1. [Change of NK Cell Number in Peripheral Blood of Patients with Mantle Cell Lymphoma and Its Clinical Significance]. Han DL; Han YY; Bao YL; Zhao WX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):772-776. PubMed ID: 28641633 [TBL] [Abstract][Full Text] [Related]
2. Low absolute NK cell counts in peripheral blood are associated with inferior survival in patients with mantle cell lymphoma. Zhou XH; Zhang XY; Liang JH; Zhu HY; Wang L; Xia Y; Cao L; Wu W; Fan L; Li JY; Xu W Cancer Biomark; 2019; 24(4):439-447. PubMed ID: 30932881 [TBL] [Abstract][Full Text] [Related]
3. Simplified MIPI-B prognostic stratification method can predict the outcome well-retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China. He JS; Chen X; Wei GQ; Sun J; Zheng WY; Shi JM; Wu WJ; Zhao Y; Zheng GF; Huang H; Cai Z Medicine (Baltimore); 2019 Jan; 98(1):e13741. PubMed ID: 30608386 [TBL] [Abstract][Full Text] [Related]
4. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network. Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679 [TBL] [Abstract][Full Text] [Related]
6. [Clinical Significance of Detecting CD4 Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291 [TBL] [Abstract][Full Text] [Related]
7. [Correlation of CD4 Li YL; Qin XQ; Guo LY; Hou XX; Chao Y; Ma YP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1129-1135. PubMed ID: 39192409 [TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of 140 cases of mantle cell lymphoma]. Hu MW; Lou YJ; Yang M; Wang HF; Wang L; Jin J Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):390-395. PubMed ID: 29860768 [No Abstract] [Full Text] [Related]
9. PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. Zhang X; Han Y; Nie Y; Jiang Y; Sui X; Ge X; Liu F; Zhang Y; Wang X J Mol Med (Berl); 2023 May; 101(5):595-606. PubMed ID: 37126184 [TBL] [Abstract][Full Text] [Related]
10. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma. Yoo C; Yoon DH; Kim S; Huh J; Park CS; Park CJ; Lee SW; Suh C Hematol Oncol; 2016 Mar; 34(1):22-7. PubMed ID: 25689467 [TBL] [Abstract][Full Text] [Related]
11. Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases. Veselá P; Tonar Z; Sálek D; Vokurka S; Trněný M; Kodet R; Moulis M; Kašparová P; Vernerová Z; Velenská Z; Stříteský J; Michal M; Boudová L Virchows Arch; 2014 Nov; 465(5):587-97. PubMed ID: 25048573 [TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436 [TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management. Vose JM Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091 [TBL] [Abstract][Full Text] [Related]
14. Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan. Chihara D; Asano N; Ohmachi K; Kinoshita T; Okamoto M; Maeda Y; Mizuno I; Matsue K; Uchida T; Nagai H; Nishikori M; Nakamura S; Ogura M; Suzuki R Br J Haematol; 2015 Sep; 170(5):657-68. PubMed ID: 25953436 [TBL] [Abstract][Full Text] [Related]
15. Smoldering mantle cell lymphoma. Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179 [TBL] [Abstract][Full Text] [Related]
16. [Clinical features and prognostic factors of elderly patients with mantle cell lymphoma]. Hao XY; Yang P; Zhang W; Liu H; Sun XH; Xiao XB; Wang JW; Li ZL; Li LH; Wang SY; He J; Li XL; Jing HM Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):495-500. PubMed ID: 37550206 [No Abstract] [Full Text] [Related]
18. [Relationship of Expression of Circ_cgga162 with the Prognosis of Patients with Mantle Cell Lymphoma]. Li Y; Jia ZW; Liu JX; Ye JW; Kong XY; Yang ZF; Liu XY; Luo JM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):876-880. PubMed ID: 32552951 [TBL] [Abstract][Full Text] [Related]
19. [Clinical Characteristics and Outcome of 66 Cases of Mantle Cell Lymphomas]. Wu Y; Wang H; Liu XJ; Wang YY; Zhao WL; Li JM; Shen ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1036-1041. PubMed ID: 28823264 [TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of clinical risk factors in mantle cell lymphoma. Hoster E Semin Hematol; 2011 Jul; 48(3):185-8. PubMed ID: 21782060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]